US FDA approved Mirati Therapeutics Inc.’s lung cancer drug adagrasib
United States: (Web Desk) The US Food and Drug Administration (FDA) approved Mirati Therapeutics Inc’s (MRTX.O) lung cancer drug adagrasib, the company said, sending its shares up more than 8% in extended trading. Mirati’s drug has been…
